Trial Profile
Study of two schedules of infliximab maintenance therapy in ankylosing spondylitis: comparison of infusion every 6 weeks versus infusion on demand
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Methotrexate
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 02 Apr 2007 New trial record.